Study of 2550 donor-recipient demographic characteristics associated with kidney transplantation in Isfahan Province, Iran

Farhad Tadayon, Ali Shariati, Zahra Tolou-Ghamari

Abstract


Due to a significant improvement in quality and quantity of life in most patients with end stage renal disease, kidney transplantation proved to be the best form of cost-effective treatment. The aim of this study was to analyze donor-recipient (n=2550) demographic characteristics associated with kidney transplantation in Isfahan Province/Iran. Demographic and clinical data were recorded in d-base and analyzed using SPSS for windows. A total of (recipient vs donor), 468 vs 63 females and 949 vs 1070 males were identified. The mean age of recipient vs donor was 42.5 ± 15.4 (range 2–87) vs 29.8 ± 6.1 (range 1–75) years (p<0.05). Age in 93% of donor was ranged between 20 to 40 years and in the 92% of recipients age was ranged between 20 to 70 years. With a significant p<0.006, the mean age of kidney transplanted recipients was higher in males than in females. The mean hospital stay was 20.6 days (range 1 to 180 days). In conclusion there was a significant difference between recipient and donor related to mean age and gender. An increase in the number of transplanted kidney recipients from 2008 to 2016, recommended the benefit of further study toward the impact of time to create the vascular anastomoses, graft survival and evidence-based pharmacotherapy strategy in Isfahan, Iran.


Keywords


Demographic, Kidney, Recipients, Donors

Full Text:

PDF

References


Tolou-Ghamari Z, Mortazavi M, Palizban AA, Najafi MR. The investigation of correlation between Iminoral concentration and neurotoxic levels after kidney transplantation. Adv Biomed Res 4: 59, 2015.

Tolou-Ghamari Z, Palizban AA, Gharavi M. Cyclosporine trough Concentration rejection relationship after kidney transplantation. Indian J Pharmacol 35: 395-396, 2003.

Tolou-Ghamari Z, Palizban AA. The history of liver and renal transplantation. The Internet Journal of Pharmacology 2(1), 2003.

Arenas-Bonilla AJ, Campos-Hernández JP, Carrasco-Valiente J, Márquez-López FJ, Ruiz-García JM, Sánchez-Gónzalez A, Salamanca-Bustos JJ, Regueiro-López JC, Navarro-Cabello MD, Requena-Tapia MJ. Influence of donor and recipient ages in survival of simultaneous pancreas-kidney transplantation. Transplant Proc 48:3033-3036, 2016.

Molnar MZ, Nagy K, Remport A, Tapolyai MB, Fülöp T, Kamal F, Kovesdy CP, Mucsi I, Mathe Z. Inflammatory markers and outcomes in kidney transplant recipients. Transplantation 101:2152-2164, 2017.

McGregor TB, Rampersad C, Patel P. Expanding living kidney donor criteria with ex-vivo surgery for renal anomalies. Can Urol Assoc J 10:301-305, 2016.

Jones J, Rosaasen N, Taylor J, Mainra R, Shoker A, Blackburn D, Wilson J, Mansell H. Health literacy, knowledge, and patient satisfaction before kidney transplantation. Transplant Proc 48:2608-2614, 2016.

Szabo-Pap M, Zadori G, Fedor R, Illesy L, Toth F, Kanyari Z, Kovacs DA, Nemes B.Surgical complications following kidney transplantations: A single-center study in Hungary. Transplant Proc 48:2548-2551, 2016.

McGee J, Magnus JH, Islam TM, Jaffe BM, Zhang R, et al. Donor-recipient gender and size mismatch affects graft success after kidney transplantation. J Am Coll Surg 210:718-726, 2010.

Collaborative Transplant Study. http://www. ctstransplant.org/

Gratwohl A, Dohler B, Stern M, Opelz G. H-Y as a minor histocompatibility antigen in kidney transplantation: a retrospective cohort study. Lancet 372:49-53, 2008.

MZ Molnar, Kovesdy CP, Bunnapradist S, Streja E, Mahesh Krishnan et al. Donor race and outcomes in kidney transplant recipients. Clin Transplant 27:37-51, 2013.

Mazdak H, Tolou-Ghamari Z. Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran. Arab J Urol 16:206-210, 2018.

Tolou-Ghamari Z, Palizban AA, Tredger JM.

Clinical monitoring of tacrolimus after liver transplantation using pentamer formation assay and microparticle enzyme immunoassay. Drugs in R & D5:17-22, 2004.

Bendorf A, Pussell BA, Kelly PJ, Kerridge IH. Socioeconomic, demographic and policy comparisons of living and deceased kidney transplantation rates across 53 countries. Nephrology (Carlton) 18:633-640, 2013.

Purnell TS, Luo X, Cooper LA, Massie AB, Kucirka LM, Henderson ML, Gordon EJ, Crews DC, Boulware LE, Segev DL. Association of Race and Ethnicity with Live Donor Kidney Transplantation in the United States from 1995 to 2014. JAMA 319:49-61, 2018.

Wang M, Zhang H, Zhou D, Qiao YC, Pan YH, Wang YC, Zhao HL. Risk for cancer in living kidney donors and recipients. J Cancer Res Clin Oncol. 2018 Jan 22.

Takemoto S, Terasaki PI. Donor age and recipient age. Clin Transpl. 1988:345-56.

Stolyar AG, Budkar LN, Solodushkin SI, Iumanova IF. Influence of Factors Associated With the Deceased-Donor on Kidney Transplant Outcomes. Exp Clin Transplant 13:394-401, 2015.

Kucuk M, Sever MS, Turkmen A, Sahin S, Kazancioglu R, Ozturk S, Eldegez U. Demographic analysis and outcome features in a transplant outpatient clinic. Transplant Proc 37:743-746, 2005.

Matas AJ, Gillingham KJ, Elick BA, Dunn DL, Gruessner RW, Payne WD, Sutherland DE, Najarian JS. Risk factors for prolonged hospitalization after kidney transplants. Clin Transplant 11:259-264, 1997.

Tolou-Ghamari Z, Najafi MR, Habibabadi JM, Zare M. Preliminarily Analysis of Carbamazepine (CBZ) C0 in Patients Visited Isfahan Epileptic Clinics. Int J Prev Med 4(Suppl 2):S343-346. 2013.


Refbacks

  • There are currently no refbacks.


Best Quality Medical Supplies is a registered company in Untied States specializing in sales of medical equipment and supplies. We are a distributor for hospitals, doctor offices, medical clinics, nursing schools, and nursing homes within
the United States. We also provide services for overseas clients. Click here for details and orders.




My website has truly excellent support, going well beyond what's expected from the customer. Check them out here.